Perspective · 10 Sep 2026
Conference abstractPublished 22 Oct 2012
Reduced immunogenicity of chromatin modifying agents expanded human cord blood grafts
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The limited number of hematopoietic stem cells (HSC) within a single unit of cord blood (CB) currently limits its use as an alternate graft source. Using chromatin modifying agents (CMA), including 5aza-2-deoxycytidine (5azaD) and trichostatin A (TSA), we have developed a culture strategy which allows for 7- to 10-fold expansion of transplantable HSC. Here we have assessed the allostimulatory capacity of CMA-expanded CB grafts. The co-expression of immunophenotypic markers of dendritic cells (DC) such as HLA-DR/CD86 and HLA-DR/CD11c, were significantly reduced in 5azaD/TSA-expanded grafts compared to control. In addition, the allostimulatory capacity of CMA-expanded grafts, as measured by mixed lymphocyte culture, was dramatically reduced compared to control. We hypothesized that the reduction in allostimulatory capacity of CMA expanded grafts is due to inhibition of DC differentiation or promotion of apoptosis in culture. It has been previously shown that STAT3 is indispensible in the commitment of HSC into DC. 5azaD/TSA-expanded cells express more STAT3 transcripts than control, but the expression of two inhibitors of STAT3, p21 and GATA1, are also increased significantly. LINE-1 assay, as surrogate of global methylation, shows that 5azaD/TSA-expanded cells are hypomethylated, and specifically the promoters of GATA1 but not STAT3 nor p21. However, both STAT3 protein and phosphorylation are shown to be increased in CMA expanded grafts. When expanded CB cells are grown in conditions which are permissive to DC generation, 5azaD/TSA-expanded cells produce fewer net numbers of DC than control. However, when normalized to the number of CD14+ cells at the end of expansion culture the efficiency of DC generation by 5azaD/TSA expanded graft was comparable to control cultures. Taken together, our studies indicate that the reduced allostimulatory capacity of 5azaD/TSA-expanded cells is likely due to reversible inhibition of an early stage of DC differentiation.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Nadim Mahmud”
